Valyn S Bahm is a notable inventor based in Phoenixville, PA, who has made significant contributions to the field of dermatology. He holds six patents, focusing primarily on innovative treatments for actinic keratosis. His work aims to improve patient outcomes through more effective and convenient dosing regimens.

Latest Patents

Bahm's latest patents include a 2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod. These patents describe pharmaceutical formulations and methods for the topical or transdermal delivery of imiquimod, specifically designed to treat actinic keratosis with shorter therapy durations than those currently prescribed for the commercially available Aldara® 5% imiquimod cream. The formulations aim to deliver an efficacious dose of imiquimod while maintaining an acceptable safety profile, making treatment more convenient for patients.

Career Highlights

Valyn S Bahm is associated with Medicis Pharmaceutical Corporation, where he has been instrumental in developing innovative dermatological solutions. His work has contributed to advancements in the treatment of skin conditions, particularly actinic keratosis.

Collaborations

Bahm has collaborated with notable colleagues, including Michael T Nordsiek and Sharon F Levy, who have also contributed to the field of dermatology.

Conclusion

Valyn S Bahm's innovative work in dermatological treatments, particularly for actinic keratosis, showcases his commitment to improving patient care through effective and convenient therapies. His contributions continue to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.